43 related articles for article (PubMed ID: 38483616)
21. GATA6-AS1 inhibits ovarian cancer cell proliferation and migratory and invasive abilities by sponging miR-19a-5p and upregulating TET2.
Xu H; Wang X; Zhang Y; Zheng W; Zhang H
Oncol Lett; 2021 Oct; 22(4):718. PubMed ID: 34429758
[TBL] [Abstract][Full Text] [Related]
22. Development and Carcinogenesis: Roles of GATA Factors in the Sympathoadrenal and Urogenital Systems.
Moriguchi T
Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33803938
[TBL] [Abstract][Full Text] [Related]
23. MYC as a target for cancer treatment.
Duffy MJ; O'Grady S; Tang M; Crown J
Cancer Treat Rev; 2021 Mar; 94():102154. PubMed ID: 33524794
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance.
Fatma H; Maurya SK; Siddique HR
Semin Cancer Biol; 2022 Aug; 83():166-176. PubMed ID: 33220458
[TBL] [Abstract][Full Text] [Related]
25. Silencing of long non-coding RNA SOX21-AS1 inhibits lung adenocarcinoma invasion and migration by impairing TSPAN8 via transcription factor GATA6.
Xu Y; Wu H; Wu L; Xu L; Li J; Wang Q; Pu X
Int J Biol Macromol; 2020 Dec; 164():1294-1303. PubMed ID: 32698071
[TBL] [Abstract][Full Text] [Related]
26. GATA6 Exerts Potent Lung Cancer Suppressive Function by Inducing Cell Senescence.
Chen W; Chen Z; Zhang M; Tian Y; Liu L; Lan R; Zeng G; Fu X; Ru G; Liu W; Chen L; Fan Z
Front Oncol; 2020; 10():824. PubMed ID: 32596145
[TBL] [Abstract][Full Text] [Related]
27. Prognosis and Treatment of Non-Small Cell Lung Cancer in the Age of Deep Learning.
Howard FM; Pearson AT
JAMA Netw Open; 2020 Jun; 3(6):e206368. PubMed ID: 32492160
[No Abstract] [Full Text] [Related]
28. Tumor progression and chromatin landscape of lung cancer are regulated by the lineage factor GATA6.
Arnal-Estapé A; Cai WL; Albert AE; Zhao M; Stevens LE; López-Giráldez F; Patel KD; Tyagi S; Schmitt EM; Westbrook TF; Nguyen DX
Oncogene; 2020 Apr; 39(18):3726-3737. PubMed ID: 32157212
[TBL] [Abstract][Full Text] [Related]
29. Solute carrier proteins and c-Myc: a strong connection in cancer progression.
Panda S; Banerjee N; Chatterjee S
Drug Discov Today; 2020 May; 25(5):891-900. PubMed ID: 32105718
[TBL] [Abstract][Full Text] [Related]
30. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.
Liang G; Meng W; Huang X; Zhu W; Yin C; Wang C; Fassan M; Yu Y; Kudo M; Xiao S; Zhao C; Zou P; Wang Y; Li X; Croce CM; Cui R
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4347-4357. PubMed ID: 32041891
[TBL] [Abstract][Full Text] [Related]
31. The roles and controls of GATA factors in blood and cardiac development.
Dobrzycki T; Lalwani M; Telfer C; Monteiro R; Patient R
IUBMB Life; 2020 Jan; 72(1):39-44. PubMed ID: 31778014
[TBL] [Abstract][Full Text] [Related]
32. GATA factor transcriptional activity: Insights from genome-wide binding profiles.
Romano O; Miccio A
IUBMB Life; 2020 Jan; 72(1):10-26. PubMed ID: 31574210
[TBL] [Abstract][Full Text] [Related]
33. GATA6-upregulating autophagy promotes TKI resistance in nonsmall cell lung cancer.
Ma R; Li X; Liu H; Jiang R; Yang M; Zhang M; Wang Y; Zhao Y; Li H
Cancer Biol Ther; 2019; 20(9):1206-1212. PubMed ID: 31092103
[TBL] [Abstract][Full Text] [Related]
34. GATA6: a new predictor for prognosis in ovarian cancer.
Shen W; Niu N; Lawson B; Qi L; Zhang J; Li T; Zhang H; Liu J
Hum Pathol; 2019 Apr; 86():163-169. PubMed ID: 30633927
[TBL] [Abstract][Full Text] [Related]
35. GATA transcription factors in development and disease.
Tremblay M; Sanchez-Ferras O; Bouchard M
Development; 2018 Oct; 145(20):. PubMed ID: 30348673
[TBL] [Abstract][Full Text] [Related]
36. miR-196b promotes lung cancer cell migration and invasion through the targeting of GATA6.
Li H; Feng C; Shi S
Oncol Lett; 2018 Jul; 16(1):247-252. PubMed ID: 29928408
[TBL] [Abstract][Full Text] [Related]
37. Retinoic Acid affects Lung Adenocarcinoma growth by inducing differentiation via GATA6 activation and EGFR and Wnt inhibition.
Zito G; Naselli F; Saieva L; Raimondo S; Calabrese G; Guzzardo C; Forte S; Rolfo C; Parenti R; Alessandro R
Sci Rep; 2017 Jul; 7(1):4770. PubMed ID: 28684780
[TBL] [Abstract][Full Text] [Related]
38.
Camarda R; Williams J; Goga A
Front Cell Dev Biol; 2017; 5():35. PubMed ID: 28443280
[TBL] [Abstract][Full Text] [Related]
39. GATA6 is overexpressed in breast cancer and promotes breast cancer cell epithelial-mesenchymal transition by upregulating slug expression.
Song Y; Tian T; Fu X; Wang W; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
Exp Mol Pathol; 2015 Dec; 99(3):617-27. PubMed ID: 26505174
[TBL] [Abstract][Full Text] [Related]
40. Control of alveolar differentiation by the lineage transcription factors GATA6 and HOPX inhibits lung adenocarcinoma metastasis.
Cheung WK; Zhao M; Liu Z; Stevens LE; Cao PD; Fang JE; Westbrook TF; Nguyen DX
Cancer Cell; 2013 Jun; 23(6):725-38. PubMed ID: 23707782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
